Insider filing · PRCT

Antal Rohit Desai bought $10.4M of PROCEPT BioRobotics (PRCT)

Executed Mar 5, disclosed Mar 9, 4 days later.

Over the 21 trading sessions from the disclosed entry session (Mar 9), the stock returned -2.6% (delay-adjusted); from the execution session (Mar 5), -4.6%. Derived: entry at the session's open, exit at the close 20 sessions later.

AD Antal Rohit Desai Director profile →

Antal Rohit Desai (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in PROCEPT BioRobotics Corporation (PRCT). Across 1 priced purchase filing, the average 21-session return was -4.6% from execution and -2.6% from disclosure (delay-adjusted; derived). The largest single filing was $10.4M of PRCT (424,962 sh across 6 lots, as filed), executed Mar 5.

PRCT PROCEPT BioRobotics Corporation PRCT · Healthcare · 21 filings in 24 months ticker →

Healthcare · PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and interna…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→